Zepbound , the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
Lilly's Taltz and Zepbound used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
Lilly's Retevmo delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
Lilly's Retevmo delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
Red Metals Corp Invites Shareholders and Investment Community to Visit Them at Booth 2538 at PDAC 2026 in Toronto, March 1-4
Silver Hammer Closes CDN$3,913,617 Non-Brokered Private Placement Pursuant to Listed Issuer Exemption
